10-K: TerrAscend Corp. Reports Fiscal Year 2024 Results, Navigates Competitive Cannabis Market

TerrAscend Corp. releases its 10-K filing for fiscal year 2024, detailing financial performance, strategic initiatives, and risk factors in the evolving cannabis industry.

Summary

• TerrAscend Corp. reported its financial results for the fiscal year ended December 31, 2024.
• The company operates in the cannabis industry with vertically integrated operations in several states and retail operations in Canada.
• Revenue for 2024 was $306.677 million, a decrease from $317.328 million in 2023, attributed to declining retail sales in Michigan and New Jersey.
• The company is focused on expanding gross margins and navigating competitive pressures.
• The company has an accumulated deficit of $778.514 million as of December 31, 2024.
• The company has taken the position that it does not owe taxes attributable to the application of Section 280E of the Code.
• The company has a share repurchase program in place, authorizing the repurchase of up to $10 million of its common shares.
• The company has outstanding debt of $204.545 million as of December 31, 2024.
• The company has identified and quickly contained and remediated several non-material cybersecurity incidents in 2024.
• The company has 1,163 employees as of December 31, 2024, 134 of whom are subject to a collective bargaining agreement.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the company has vertically integrated operations and a share repurchase program, it also faces declining revenue, net losses, and intense competition. The company's future outlook is uncertain, and it faces several risks related to regulations, market conditions, and financial performance.

Positives

• The company has vertically integrated operations in key cannabis markets.
• The company has a share repurchase program in place.
• The company has identified and quickly contained and remediated several non-material cybersecurity incidents in 2024.
• The company has a diverse team and strives to foster a welcoming culture where employees can make an impact on the company's success.
• The company is committed to providing a safe and secure work environment in accordance with applicable labor, safety, health, anti-discrimination and other workplace laws.

Negatives

• Revenue decreased to $306.677 million in 2024 from $317.328 million in 2023.
• The company reported a net loss of $72.670 million in 2024.
• The company has an accumulated deficit of $778.514 million as of December 31, 2024.
• The company faces intense competition in the cannabis market.
• The company is subject to risks inherent in agricultural operations.
• The company may face unfavorable publicity or consumer perception of the safety, efficacy and quality of its cannabis products.

Risks

• The company may be subject to unfavorable tax treatment under U.S. federal income tax law.
• Cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change.
• The company may be at a higher risk of an IRS audit.
• The company's business is subject to applicable anti-money laundering laws and regulations.
• The company's business relies heavily on its ability to obtain and maintain required licenses.
• Compliance with regulations regarding cannabis is difficult, because the regulation of cannabis is uncertain and frequently changes.
• There is a substantial risk of regulatory or political change with respect to cannabis.
• The company may encounter increasingly strict environmental health and safety regulations.
• The company's products may be subject to product recalls or returns.
• The company faces an inherent risk of product liability claims.
• The company may be subject to constraints on and differences in marketing its products under varying regulatory restrictions.
• The company may face difficulties in enforcing its contracts because cannabis and cannabis-related activities are not legal under U.S. federal law.
• The company may require substantial additional financing to operate its business and it may face difficulties acquiring additional financing on terms acceptable to the company, or at all.
• The company is dependent on suppliers and key inputs for the cultivation, extraction and production of cannabis products.
• The company's intellectual property may be difficult to protect.
• The company (and the third parties with whom it works) faces physical security risks, as well as risks related to its information technology systems data, potential cyber or phishing -attacks, and security incidents.
• The company may be adversely impacted by rising or volatile energy costs.
• The company's internal controls over financial reporting may not be effective.
• The company's business could be adversely affected by economic downturns, inflation, increases in interest rates, natural disasters, public health crises, political crises, geopolitical events, such as the war in Ukraine and the hostilities in the Middle East, policy changes, including tariffs, or other macroeconomic conditions.
• The company faces intense competition and its business could be adversely affected by other businesses in a better competitive position.
• The company has historically had continued losses which could have a material negative effect on the company's business and prospects and impact its ability to continue as a going concern.
• The company's inability to attract and retain key personnel, or its inability to maintain relations with its employees, unions and other employee representatives, could materially adversely affect its business.
• The company and its investors may have difficulty enforcing their legal rights.
• The company (and the third parties with whom it works) is subject to stringent and evolving U.S. and foreign laws, regulations, rules, contractual obligations, policies and other obligations related to data privacy and security.
• The company may not have access to U.S. bankruptcy protections available to non-cannabis businesses.
• The development of the company's products is complex and requires significant investment.
• The company faces exposure to fraudulent or illegal activity by employees, contractors and consultants.
• Consolidation in the cannabis industry and other changes to the competitive environment can impact the company's margins and profitability.
• The cannabis industry and market are relatively new, and this industry and market may not continue to exist or grow as expected.
• The company may be affected by currency fluctuations.
• The company's use of joint ventures may expose the company to risks associated with jointly owned investments.
• The success of the company's business depends, in part, on its ability to successfully integrate recently acquired businesses and to retain key employees of acquired businesses, and the failure to do so may negatively affect the company's business.
• There can be no assurance that the company's current and future strategic alliances will have a beneficial impact on the company's business, financial condition and results of operations.
• The company may not realize the benefits of its growth strategy, which could have an adverse effect on its business.
• The company's voting control is concentrated.
• Additional issuances of the company's securities may result in dilution.
• Sales of substantial amounts of Common Shares may have an adverse effect on the market price of the Common Shares.
• An investor may face liquidity risks with an investment in the Common Shares.
• The price of the Common Shares may be volatile, and may be adversely affected by the price of cannabis.
• A return on the company's securities is not guaranteed.
• Cannabis related business rules or policies may restrict certain financial institutions from holding the company's securities, which may make its securities less liquid.
• The company's management will continue to have broad discretion over the use of the proceeds the company receives in connection with public offerings, private placements, warrant exercises and loans, as applicable, and may not apply such proceeds in ways that increase the value of the Common Shares.
• The company cannot guarantee that it will repurchase the maximum number of Common Shares pursuant to the Share Repurchase Program or that the Share Repurchase Program will enhance long-term shareholder value.
• The preferred shares in the capital of the company have a liquidation preference over the Common Shares, which could limit the company's ability to make distributions to the holders of Common Shares in certain circumstances.
• Investors could be disqualified from owning a direct or indirect interest in the company.
• The company does not intend to pay dividends on the Common Shares for the foreseeable future and, consequently, investors' ability to achieve a return on their investment will depend on appreciation in the price of the Common Shares.
• Penny stock rules may make buying or selling the company's securities difficult, which may make its securities less liquid and make it harder for investors to buy and sell such securities.
• The company may not be able to obtain necessary permits and authorizations.
• The company may be subject to litigation, which could divert the attention of management and cause the company to expend significant resources.
• Due to the uncertainty regarding the application of the Employee Retention Tax Credit to businesses in the cannabis industry, there is a risk that a determination could be made that the company is not eligible for the Employee Retention Tax Credit distributions it has received, which may negatively impact the company.
• The company faces risks and hazards that may not be covered by insurance.
• The company has incurred and will continue to incur substantial costs as a result of operating as a public company in Canada and the United States, and its management will continue to devote substantial time to new compliance initiatives.
• The company is currently an emerging growth company within the meaning of the Securities Act and to the extent that the company has taken advantage of certain exemptions from disclosure requirements available to emerging growth companies, this could make its securities less attractive to investors and may make it more difficult to compare the company's performance with other public companies.

Future Outlook

The Company expects to fund any additional future requirements through cash from ongoing operations, private placements and public offerings of equity or debt securities, additional debt from additional creditors, sale of real property, sale leaseback transactions, and exercise of options and warrants.

Industry Context

The cannabis industry is subject to evolving regulations, increasing competition, and potential market fluctuations, all of which impact the company's financial performance and strategic decisions.

Comparison to Industry Standards

• The document mentions competitors such as Green Thumb Industries Inc., Curaleaf Holdings, Inc., Trulieve Cannabis Corp., Cresco Labs Inc., Verano Holdings Corp., Jushi Holdings Inc., AYR Wellness Inc., Ascend Wellness Holdings, Inc., and The Cannabist Company Holdings Inc.
• These companies are vertically integrated competitors with established operating histories in North America.
• The document also mentions existing retail competitors, government competitors, illicit market competitors, exiting competitors, and existing wholesale competitors.
• The document does not provide a direct comparison of TerrAscend's results to these companies, but it does mention that some competitors may have greater financial resources, market access, and manufacturing and marketing experience than TerrAscend.

Legal Proceedings

• In the ordinary course of business, the Company is involved in a number of lawsuits incidental to its business, including litigation related to intellectual property, product liability, employment, and commercial matters.
• On August 9, 2023, AEY Capital LLC (AEY), a licensed subsidiary of TerrAscend, filed a lawsuit in Oakland County Circuit Court (the 'Oakland Court') against Pure X, LLC (Pure X) seeking damages in the amount of $14,969 (the AEY Claim).
• This matter was settled between the parties and dismissed with prejudice by the Oakland Court on June 28, 2024.

Related Party Transactions

• Certain funds controlled by Jason Wild, a related party of the Company, invested $5,500 of the total loan principal balance of the FG Loan, as a member of the loan syndicate.
• The Private Placements constitute a related party transaction because related persons, which consisted of key management and directors of the Company participated in the transaction.
• The Company's Executive Chairman, participated, directly and indirectly, in the Private Placement and acquired 800,002 units for gross proceeds of $1,200.
• In total, the related persons acquired, in the aggregate, 2,000 debentures and 825,734 units in connection with the Private Placements for aggregate gross proceeds of $3,239.

Stakeholder Impact

• Shareholders may experience dilution from additional issuances of the company's securities.
• Shareholders may face liquidity risks with an investment in the Common Shares.
• Employees may be affected by changes in the company's operations, including potential layoffs or restructuring.
• Customers may be affected by changes in the company's products, services, or pricing.
• Suppliers may be affected by changes in the company's purchasing patterns or financial stability.
• Creditors may be affected by the company's ability to repay its debts.

Next Steps

• The company intends to add new facilities or expand existing facilities as it adds employees.
• The company intends to meet its capital commitments through any or all of the sources of capital noted above.

Key Dates